Famotidine Dosing for 4.99 kg Infant
For a child weighing 4.99 kg, administer 2.5 mg of famotidine (0.3 mL of the 40 mg/5 mL suspension) once daily, as this infant is under 3 months of age based on typical weight-for-age parameters.
Dosing Calculation and Rationale
The recommended pediatric dose of famotidine is 1 mg/kg/day divided in 2 doses for children over 3 months of age 1. However, critical age-based adjustments are necessary:
Age-Dependent Dosing Strategy
For infants under 3 months:
- Administer once daily dosing (not twice daily)
- This adjustment is essential because renal clearance and plasma clearance of famotidine are significantly decreased in infants under 3 months compared to older infants 2
- Pharmacokinetic studies demonstrate that infants under 3 months have immature renal function, which is the primary elimination route for famotidine 2
For infants over 3 months:
- Administer every 12 hours (twice daily)
- Pharmacokinetic parameters in these older infants are similar to children and adults 2
Specific Dose for This Patient
Given the weight of 4.99 kg:
- Total daily dose: 4.99 kg × 1 mg/kg = approximately 5 mg/day
- If under 3 months: 5 mg once daily = 0.625 mL of suspension (round to 0.6 mL for practical administration)
- If over 3 months: 2.5 mg twice daily = 0.3 mL per dose given every 12 hours
Critical Clinical Considerations
Age Determination is Essential
A 4.99 kg infant is most likely under 3 months of age based on typical growth curves, making once-daily dosing appropriate. However, you must verify the actual age:
- If confirmed under 3 months: 0.6 mL once daily
- If over 3 months: 0.3 mL twice daily
Formulation Details
The oral suspension (40 mg/5 mL = 8 mg/mL) is cherry-banana-mint flavored and FDA-approved for ages 1 month to 16 years 1. This formulation is specifically designed for pediatric use and allows precise dosing in small infants.
Duration and Monitoring
- Clinical trials in infants used doses ranging from 0.5 to 1.0 mg/kg with treatment courses of 2-8 weeks 3
- The 0.5 mg/kg dose showed significant improvements in regurgitation frequency 3
- Monitor for potential adverse effects including agitation, irritability (sometimes manifested as head-rubbing), somnolence, and headache 3
Bioavailability Considerations
Oral bioavailability in infants is approximately 50% 2, 4, similar to adults. The drug reaches peak plasma levels in 1-3 hours and maintains gastric pH elevation for approximately 13.5 hours in pediatric patients at 0.5 mg/kg dosing 5.
Common Pitfalls to Avoid
- Do not use twice-daily dosing in infants under 3 months - this can lead to drug accumulation due to immature renal function
- Do not use the 20 mg or 40 mg tablets - the FDA label explicitly states these are not recommended for patients under 40 kg 5
- Do not assume adult dosing intervals apply - age-adjusted regimens are mandatory 2